Drugs Made in America AcquisDMAA
13F holders, Q2 2026 (June 30)23holders −16
1new positions
17sold out
$10.44avg. 13F price*
At the end of Q2 2026, 23 institutions reported holding Drugs Made in America Acquis (DMAA) in their 13F filings, down 16 from Q1 2026. 1 opened new positions and 17 sold out. The largest holders were Karpus Management, Inc. ($26.7M), Mizuho Securities USA LLC ($21.9M) and Polar Asset Management Partners Inc. ($12.2M).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2847J104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.2M |
| Exits | 17 | $50.8M |
All 13F filers, Q1 2026 → Q2 2026: 207,966 shares bought and 11,113,018 shares sold, net −10,905,052 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Karpus Management, Inc. | 0.77% | Reduce -0.9% | 2,507,817 | $26.7M |
| Mizuho Securities USA LLC | 0.36% | Add +3.5% | 2,069,605 | $21.9M |
| Polar Asset Management Partners Inc. | 0.29% | Reduce -28.4% | 1,146,000 | $12.2M |
| Glazer Capital, LLC | 0.27% | Reduce -40.4% | 999,899 | $10.6M |
| Wolverine Asset Management LLC | 0.46% | Reduce -46.4% | 832,093 | $8.9M |
| Highbridge Capital Management LLC | 0.57% | Reduce -38.9% | 809,054 | $8.6M |
| First Trust Capital Management L.P. | 0.49% | Reduce -64.9% | 786,459 | $8.4M |
| Heights Capital Management, Inc. | 1.62% | Reduce -0.3% | 648,083 | $6.9M |
| Westchester Capital Management, LLC | 0.31% | Reduce -65.1% | 581,790 | $6.2M |
| Aristeia Capital, L.L.C. | 0.14% | Reduce -60.3% | 350,000 | $3.7M |
| Sona Asset Management (us) LLC | 0.08% | No change | 162,795 | $1.7M |
| Clear Street Group Inc. | 0.01% | Add +8.0% | 382,440 | $1.6M |
| RLH Capital LLC | 0.59% | Reduce -63.5% | 115,606 | $1.2M |
| Logan Stone Capital, LLC | 0.25% | New | 109,959 | $1.2M |
| Toronto Dominion Bank | 0.00% | Reduce -50.9% | 100,000 | $1.1M |
| Meteora Capital, LLC | 0.09% | Reduce -74.3% | 97,837 | $1.0M |
| Quarry LP | 0.11% | Reduce -75.4% | 65,551 | $698K |
| Geode Capital Management, LLC | 0.00% | No change | 62,273 | $663K |
| JPMorgan Chase & Co. | 0.00% | Add +0.0% | 49,891 | $531K |
| Dakota Wealth Management | 0.01% | No change | 36,400 | $388K |
| Lineage Point Capital LP | 0.07% | No change | 31,840 | $339K |
| HRT Financial LP | 0.00% | Reduce -32.8% | 18,483 | $196K |
| Morgan Stanley | 0.00% | Reduce -51.7% | 28 | $298 |
"% of holder's portfolio" is DMAA's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.